RORY MARCUS MARKS
Pharmacy in Ann Arbor, MI
License number
Michigan 4301500082
Expiration Date
Jan 31, 2020
Category
Pharmacy
Type
CS - 3
Address
Address
Ann Arbor, MI 48109
Professional information
Dr. Rory M Marks, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
University Of Michigan RHU
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-5900 (Phone)
University of Michigan Medical Center
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-5900 (Phone)
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-5900 (Phone)
University of Michigan Medical Center
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-5900 (Phone)
Procedures:
Joint Drainage, Steroid Injections, Trigger Point Injections
Conditions:
Amyloidosis, Antiphospholipid Syndrome (APS), Arthritis, Behçet's Disease, Bursitis, Calcium Pyrophosphate Dihydrate Deposition Disease (CPPD), Carpal Tunnel Syndrome, Chronic Neck Pain, Degenerative Disc Disease, Dermatomyositis, Enthesopathy of Hip (incl. Trochanteric Bursitis), Fibromyalgia, Giant Cell Arteritis, Gout, HenochâÂÂSchönlein Purpura (HSP), Immune Thrombocytopenic Purpura (ITP), Low Back Pain, Lupus Erythematosus, Osteoarthritis, Osteoarthritis of Hand or Wrist, Osteoarthritis of Hip, Osteoarthritis of Knee, Osteoarthritis of Spine, Osteopenia, Osteoporosis, Patellofemoral Pain Syndrome or Knee Pain, Polymyalgia Rheumatica (PMR), Polymyositis, Raynaud's Disease, Reiter's Syndrome (Reactive Arthritis), Rheumatoid Arthritis, Sarcoidosis, Sjögren's Syndrome, Spondylitis, Still's Disease, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Takayasu's Arteritis, Vasculitis, Wegener's Granulomatosis
Certifications:
Internal Medicine, 2000, Rheumatology, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University Of Michigan RHU
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Medical Center
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Medical Center
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
University Of New South Wales
Graduated: 1977
Royal Newcastle Hospital
Graduated: 1979
Royal Prince Alfred Hospital
St Vincents Hospital
Graduated: 1978
University New S Wales
Graduated: 1986
University Of Michigan
Graduated: 1989
University Of New South Wales
Graduated: 1977
Royal Newcastle Hospital
Graduated: 1979
Royal Prince Alfred Hospital
St Vincents Hospital
Graduated: 1978
University New S Wales
Graduated: 1986
University Of Michigan
Graduated: 1989
Rory Marcus Marks, Ann Arbor MI
Specialties:
Rheumatologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of New South Wales, Faculty of Medicine - Bachelor of Medicine, Bachelor of Surgery
Board certifications:
American Board of Internal Medicine Sub-certificate in Rheumatology (Internal Medicine)
Method And Compositions For Isolation, Diagnosis And Treatment Of Polyanion-Binding Microorganisms
US Patent:
6197568, Mar 6, 2001
Filed:
Jul 28, 1998
Appl. No.:
9/123770
Inventors:
Rory M. Marks - Ann Arbor MI
Yaping Chen - San Diego CA
Terence Maguire - Waverly Dunedin, NZ
Robert J. Linhardt - Iowa City IA
Yaping Chen - San Diego CA
Terence Maguire - Waverly Dunedin, NZ
Robert J. Linhardt - Iowa City IA
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 170, A61K 3929, A61K 3170, A01N 4304, C12N 702
US Classification:
435239
Abstract:
Methods and compositions for the isolation, diagnosis and treatment of microorganisms such as flaviviruses and other hemorrhagic fever viruses are based on the sulfated polyanion-dependent interaction of flaviviruses and hemorrhagic fever viruses, in particular dengue virus, with target cells. The cellular receptors targeted by these viruses have been identified as sulfated polyanionic glycoproteins, that include highly sulfated heparan sulfate glycosaminoglycans for some target cell types, and as a sulfated mucin on vascular endothelium. Compounds such as heparin, highly sulfated heparan sulfate, and synthetic polyanions such as Suramin, inhibit the interaction between the microorganisms and target cells, thereby disrupting the infective process.